MYMei Yuan

Mei Yuan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mei Yuan has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Danlian Zhou

    Department of Plastic Surgery and Burn, The First Affiliated Hospital of Bengbu Medical University, Bengbu City 233000, Anhui Province, China

    1 shared publication
  • Jing Xu

    Department of Plastic Surgery and Burn, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, 233000, China; Central Laboratory, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, 233000, China

    1 shared publication
  • Peijun Song

    Department of Plastic Surgery and Burn, The First Affiliated Hospital of Bengbu Medical University, Bengbu City 233000, Anhui Province, China

    1 shared publication
  • Qiu Liang

    Department of Plastic Surgery, The Affiliated Hospital of Yangzhou University, Yangzhou City 225000, Jiangsu Province, China

    1 shared publication
  • Weiwei Chu

    Department of Plastic Surgery and Burn, The First Affiliated Hospital of Bengbu Medical University, Bengbu City 233000, Anhui Province, China

    1 shared publication
  • Xiuyu Ge

    Department of Plastic Surgery and Burn, The First Affiliated Hospital of Bengbu Medical University, Bengbu City 233000, Anhui Province, China

    1 shared publication

Latest Publications

  • Open Access

    Adipose‐Derived Stem Cell Exosomes Promote Scar‐Free Healing of Diabetic Wounds via miR‐204‐5p/TGF‐ β 1/Smad Pathway

    by Peijun Song, Qiu Liang, Xiuyu Ge, Danlian Zhou, Mei Yuan, Weiwei Chu, Jing Xu

    Numerous researches have demonstrated the therapeutic potential of adipose‐derived stem cell exosomes (ADSC‐Exos) in promoting wound healing. In this study, we aimed to investigate the impact of ADSC‐Exos on diabetic wound fibroblasts and elucidate its possible mechanisms. CCK‐8, Edu, cell scratch, and Transwell tests were used to evaluate the function of ADSC‐Exos on rat skin fibroblasts (RSFs) in high‐glucose (HG) medium. The targeting effect of ADSC‐Exo‐derived microRNA (miRNA) and TGF‐ β 1 was assessed using bioinformatic analysis and then confirmed with western blot and dual luciferase reporter assays. ADSC‐Exos, miR‐204‐5p mimic, and anti‐miR‐204‐5p mimic were used to stimulate RSFs, and the levels of TGF‐ β 1/Smad pathway were analyzed by western blot. In vivo, digital photo and tissue section staining were used to evaluate the therapeutic effect of ADSC‐Exos on diabetic wounds. The data showed that ADSC‐Exos enhance the proliferation and migration of fibroblasts under HG conditions, reduce excessive myofibroblast differentiation and collagen deposition, and promote scarless healing of diabetic wounds. Additionally, miR‐204‐5p in ADSC‐Exos targets TGF‐ β 1 to inhibit p‐Smad2/3, Col I, and alpha‐smooth muscle actin ( α ‐SMA), thereby reducing fibrosis. These findings suggest that ADSC‐Exos have potential prospects for promoting diabetic wound healing.